Structural basis of kynurenine 3-monooxygenase inhibition

Emerging Concepts on Inhibitors of Indoleamine 2,3-Dioxygenase in Rheumatic Diseases

(2012) P. Filippini et al.   CURRENT MEDICINAL CHEMISTRY

Drosophila eye color mutants as therapeutic tools for Huntington disease

(2012) Edward W. Green et al.   FLY

Kynurenines in the mammalian brain: when physiology meets pathology

(2012) Robert Schwarcz et al.   NATURE REVIEWS NEUROSCIENCE

Actions of Xanthurenic Acid, a putative endogenous Group II metabotropic glutamate receptor agonist, on sensory transmission in the thalamus

(2012) C.S. Copeland et al.   NEUROPHARMACOLOGY

The aryl hydrocarbon receptor in tumor immunity

(2012) Michael Platten et al.   OncoImmunology

Treating the Periphery to Ameliorate Neurodegenerative Diseases

(2011) Peter H. Reinhart et al.   CELL

Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration

(2011) Daniel Zwilling et al.   CELL

The Kynurenine Pathway Modulates Neurodegeneration in a Drosophila Model of Huntington's Disease

(2011) Susanna Campesan et al.   CURRENT BIOLOGY

XDS

(2010) Wolfgang Kabsch   ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY

PHENIX: a comprehensive Python-based system for macromolecular structure solution

(2010) Paul D. Adams et al.   ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY

MolProbity: all-atom structure validation for macromolecular crystallography

(2009) Vincent B. Chen et al.   ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY

Control of catalysis in flavin-dependent monooxygenases

(2009) Bruce A. Palfey et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Structure of the PLP Degradative Enzyme 2-Methyl-3-hydroxypyridine-5-carboxylic Acid Oxygenase fromMesorhizobium lotiMAFF303099 and Its Mechanistic Implications

(2009) Kathryn M. McCulloch et al.   BIOCHEMISTRY

Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy

(2009) X. Liu et al.   CURRENT CANCER DRUG TARGETS